# Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment With Zanubrutinib

> **NCT06812715** · PHASE2 · RECRUITING · sponsor: **Peter MacCallum Cancer Centre, Australia** · enrollment: 40 (estimated)

## Conditions studied

- Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** Pirtobrutinib

## Key facts

- **NCT ID:** NCT06812715
- **Lead sponsor:** Peter MacCallum Cancer Centre, Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-05
- **Primary completion:** 2029-05
- **Final completion:** 2031-05
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06812715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06812715, "Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment With Zanubrutinib". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06812715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*